Before the bell: What you need to know before the US market open May 4, 2016 US stock futures are heading south in New York, following most European markets moving downwards in early afternoon trading. Asian markets recorded small losses by their close this morning. A little earlier the S&P was down by 0.64 per cent, while the Nasdaq was off by 0.72 per cent, and the Dow 0.53 per cent [...]
Deutsche Telekom’s share price slumps despite staying on target for full year numbers May 4, 2016 A strong performance in the US has failed to prop up German carrier Deutsche Telekom's share price this morning. Revenue and profits managed to beat estimates, with adjusted earnings climbing to €5.16bn (£4.1bn), against analyst expectations of €5.1bn and up 12.9 per cent year-on-year. Sales rose by 4.7 per cent to €17.6bn, versus analysts’ estimates of €17.5bn. The company also said it was on [...]
Advertising watchdog to crack down on broadband pricing after finding customers were often left confused May 4, 2016 The advertising regulator, the Advertising Standards Authority (ASA), is cracking down on broadband price claims. The changes, which will come into force on 31 October 2016, force companies to include line rental in the final price shown to customers. Earlier this year the ASA found many customers were confused by the way prices were presented, with [...]
Hedge fund boss Paul Marshall to make Brexit donation May 3, 2016 Hedge fund boss Paul Marshall is set to make a large donation to the campaign for the UK to leave the European Union. Marshall, a co-founder of one of the City’s most successful hedge funds Marshall Wace, will donate in excess of £100,000 to Vote Leave. Marshall only decided to hand over the cash in [...]
US prosecutors mull further action against Martin Shkreli in relation to his involvement with biopharmaceutical company Retrophin May 3, 2016 Martin Shkreli, the notorious former pharma chief executive, could be about to face fresh charges. Shkreli, who famously hiked the price of a drug by 5,000 per cent last year sparking a public outcry, now could face additional charges of securities fraud, federal prosecutor Winston Paes said at a hearing in New York. The future charges would relate to Shkreli's involvement [...]
TalkTalk reveals plans to scrap separate line rental charge in UK industry first May 3, 2016 TalkTalk, the telecoms company that was last year the victim of a high profile data leak, has announced it will soon stop separating out line rental from broadband prices. The move, which will come into force in the Autumn this year, comes ahead of a crack down by the Advertising Standards Authority (ASA) on price transparency this week. The fiercely competitive [...]
Halliburton’s share price slumps despite beating earnings expectations after $28bn Baker Hughes merger deal falls through May 3, 2016 Halliburton, one of the biggest oilfield services companies in the US, has posted a loss of $2.41bn (£1.65bn), or $2.81 a share. This time last year the company posted of $643m, or 76 cents a share. Total revenue over the quarter slid by a whopping 40 per cent to $4.2bn, while adjusted earnings from continuing operations came in at seven [...]
Before the bell: What you need to know before the US market open May 3, 2016 Oil prices are falling and Australian central bankers are getting jumpy. Here's what you need to know before the US markets open. Markets look set for a sharply lower open, following their European counterparts southwards. Many seem to have taken the old adage of "sell in May and go away," to heart it seems. S&P [...]
Valeant’s new chief executive has begun his job of trying to save the embattled drug maker May 3, 2016 Joseph Papa has assumed his role as chief executive of troubled Canadian drug giant Valeant Pharmaceuticals, succeeding Michael Pearson who was ousted in March. Valeant is currently wrestling with an investigation in its accounting practices and drug pricing strategy that has seen its share lose 85 per cent of their value of the last 12 months. Shares climbed slightly [...]
Pfizer beats expectations in its first quarter, the share price climbs in pre-market trading May 3, 2016 US drug giant Pfizer has beaten expectations for revenue and earnings in the first quarter of 2016. The Viagra drug maker has posted revenue of $13.01bn (£8.87bn) ahead of expectations of $12.02bn and up from $10.86bn last year. Earnings came in at $0.67 per share, compared to estimates of $0.55, according to a Reuters analyst poll. The 19.7 per cent rise in [...]
